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Aim: This study evaluates the contribution of inhibitory pain pathways that descend to the spinal cord
through the dorsolateral funiculus (DLF) on the effect of intrathecal gabapentin against spinal nerve ligation
(SNL)-induced behavioral hypersensitivity to mechanical stimulation in rats.
Main method: Rats were submitted to a sham or complete ligation of the right L5 and L6 spinal nerves and a
sham or complete DLF lesion. Next, the changes induced by intrathecal administration of gabapentin on the
paw withdrawal threshold of rats to mechanical stimulation were evaluated electronically.
Key ﬁndings: Intrathecal gabapentin (200 μg/5 μl) that was injected 2 or 7 days after surgery fully inhibited
the SNL-induced behavioral hypersensitivity to mechanical stimulation in sham DLF-lesioned rats;
gabapentin was effective against the SNL-induced behavioral hypersensitivity to mechanical stimulation
also in DLF-lesioned rats.
Signiﬁcance: The effect of intrathecally administered gabapentin against SNL-induced behavioral hypersensi-
tivity to mechanical stimulation in rats does not depend on the activation of nerve ﬁbers that descend to the
spinal cord via the DLF.© 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
The antiepileptic drug gabapentin ([1-(aminomethyl) cyclohexa-
neacetic acid]) has been used successfully in the treatment of patients
with neuropathic pain (Backonja et al., 1998; Mao and Chen, 2000;
Segal and Rordorf, 1996), and it is recommended as the ﬁrst treat-
ment option for the management of chronic pain conditions, such as
diabetic neuropathy or post-herpetic pain (Attal et al., 2010;
Dworkin et al., 2010; O'Connor and Dworkin, 2009). The clinical effec-
tiveness of gabapentin has been conﬁrmed in various animal models
of thermal and mechanical hyperalgesia (Field et al., 1997; Luo et
al., 2001; Pan et al., 1999; Partridge et al., 1998; Singh et al., 1996).
Although gabapentin is a gama-aminobutyric acid (GABA) deriva-
tive, it does not exhibit an afﬁnity for GABA binding sites, including
the GABA-A and GABA-B receptors (Taylor, 1997). Instead, it shows
a speciﬁc binding afﬁnity for the α2δ auxiliary subunit of voltage-
dependent calcium channels (Brown and Gee, 1998; Field et al.,
2006; Gee et al., 1996; Taylor, 2009; Wang et al., 1999). In fact,
there is experimental evidence demonstrating that the antiallodynic
effect of gabapentin is correlated with the up-regulation of α2δy, Faculty ofMedicine of Ribeirão
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sevier OA license.subunits in the spinal cord and/or dorsal root ganglia (Luo et al.,
2001, 2002).
The mechanism of the analgesic action of gabapentin is not fully
understood. Several studies have focused on the analgesic action of
gabapentin on the spinal cord (Abdi et al., 1998; Cheng et al., 2000;
Cho et al., 2002; Chu et al., 2011; Hwang and Yaksh, 1997; Kaneko
et al., 2000; Luo et al., 2001; Miletic and Miletic, 2000; Sandkühler,
2000; Sandkühler and Liu, 1998; Shimoyama et al., 1997). However,
the effect of systemic gabapentin against neuropathic pain in mice
was shown to be mediated by both supraspinal structures and the
spinal cord (Tanabe et al., 2005). In addition, the supraspinal-
mediated analgesic effects of gabapentin are correlated with activa-
tion of a descending pain inhibitory system that leads to the spinal
release of noradrenaline (Takeuchi et al., 2007).
Intrathecal administration of gabapentin has been shown to be
antinociceptive in rodents (Cheng et al., 2000; Kaneko et al., 2000;
Takeuchi et al., 2007) and seems to act via a mechanism that is not
mediated by the spinal release of noradrenaline and serotonin
(Takeuchi et al., 2007). However, gabapentin injected intrathecally
(Tanabe et al., 2005) or directly into the locus coeruleus (Hayashida
et al., 2007) reduces neuropathic pain in rats; moreover, the effect
is prevented by intrathecal administration of the α2-adrenergic
antagonist idazoxan.
The dorsolateral funiculus (DLF) is the main route through which
inhibitory pain pathways descend to the spinal cord (Millan, 2002).
Our present study evaluates the contribution of these speciﬁc
838 Q.M. Dias et al. / Life Sciences 91 (2012) 837–842inhibitory pain pathways on the anti‐hyperalgesic effect of intrathe-
cal gabapentin in a model of neuropathic pain in rats.
Materials and methods
Subjects
The experiments were conducted on male Wistar rats (140–
160 g) from the main animal facility of the University of São Paulo
(USP; Campus of Ribeirão Preto). The animals were housed two to a
cage with free access to food and water. The rats were also
maintained at a controlled temperature (23±1 °C) with a 12-h
light–dark cycle before and after surgery. The experiments were ap-
proved by the Commission of Ethics in Animal Research, Faculty of
Medicine of Ribeirão Preto, University of São Paulo (Number 211/
2005). The recommendations of the Committee for Research and
Ethical Issues of International Association for the Study of Pain were
followed throughout the experiments (Zimmermann, 1983).
Surgery
Spinal nerve ligation (SNL) and DLF lesioning were completed in
sequence in rats anesthetized with tribromoethanol (250 mg/kg,
i.p.). First, the right L5 and L6 spinal nerves were isolated and tightly
ligated with a chromic catgut 5–0 suture as described previously (Kim
and Chung, 1992). The incision was then closed with silk sutures.
Next, the spinal cord was exposed by laminectomy at the T8 level,
the dura mater was slit and the DLF lesion was made unilaterally by
cutting a portion of the dorsolateral quadrant of the spinal cord ipsi-
lateral to the SNL with a sharp knife while avoiding damage to the
major blood vessels supplying the cord. Lastly, hemostasis was con-
ﬁrmed, the wound was packed with gelfoam and closed, and the an-
imal was allowed to recover for 2 or 7 days before experiments.
Sham-lesion rats were subjected to similar procedures except there
was no ligation and/or DLF lesion. Rats that exhibited motor deﬁcien-
cy or a lack of increased sensitivity to innocuous mechanical stimula-
tion were excluded from additional testing.
Intrathecal injection
Two or 7 days after surgery, each rat was anesthetized with
isoﬂurane via a loose-ﬁtting, cone-shaped mask, and catheterization
of the spinal subarachnoid space was performed as previously de-
scribed (Prado, 2003). Brieﬂy, a 20-gauge Weiss needle was intro-
duced through the skin into the L5-L6 intervertebral space. The
correct positioning of the needle was assured by a typical ﬂick of
the tail or hind paw. A 12-mm length of polyethylene tubing (PE
tubing, o.d.=0.4 mm, dead space=10 μl) was then introduced
through the needle to protrude 2.0 cm into the subarachnoid space
in a cranial direction. The needle was then carefully removed, the tub-
ing was anchored to the back skin with a cotton thread suture, and
anesthesia was discontinued.
Drug or saline was injected intrathecally in a volume of 5 μl over a
period of 60 s followed by 5 μl of sterile saline at the same rate to
ﬂush the catheter. At the end of the experiment, the correct position
of the catheter was determined by motor paralysis of the hind part
of the animal occurring within 15 min after the intrathecal adminis-
tration of 2% lidocaine (10 μl) followed by saline (10 μl). To further
conﬁrm the correct catheter positioning, 1% methylene blue (10 μl)
was injected intrathecally, and the animal was then euthanized
with an overdose of sodium thiopental and intracardial perfusion
with saline followed by buffered formalin. Next, the T6–L6 spinal seg-
ment was removed, ﬁxed in formalin, and cut through the L4–L5
plane. The DLF was identiﬁed using the atlas of Paxinos and Watson
(2005), and the lesion was veriﬁed using 60-μm serial coronal sec-
tions stained with neutral red. Rats showing either the catheter tippositioned at sites other than the dorsal spinal cord or dye staining
of the paravertebral musculature were not considered for data analy-
sis. Gabapentin was purchased from Sigma (St. Louis, MO, USA).
Algesimetric testing
The mechanical threshold of rats was tested as previously
reported (Prado and Dias, 2009). The rat was placed in an acrylic
cage (12×10×17 cm) with wire-grid ﬂoors for approximately
15 min to allow behavioral acclimation. The threshold for mechanical
stimulation was measured with an automated electronic von Frey ap-
paratus (IITC Electronic Equipment, Woodland Hills, CA, USA)
consisting of a hand-held probe unit connected to a rigid plastic tip
(tip area 0.7 mm2). The plastic tip was then applied with increasing
force in an upward direction against the central area of each hind
paw. The end point was characterized by the removal of the paw
followed by clear ﬂinching movements. After paw withdrawal, the
movement of the probe was stopped, and the intensity of the pres-
sure was automatically recorded. A single trial consisted of 3 applica-
tions of the tip, once every 5 s in each hind paw. The mean of three
readings was taken as the mechanical threshold for a particular
timing. The animals were tested before SNL (BL1), immediately be-
fore catheter implantation (BL2) and then 2 h after (BL3) the catheter
implantation. The intrathecal injection was performed 5 min after the
BL3 test, and the test was repeated 15 min later, and then at 30-min
intervals for up to 105 min.
A preliminary experiment was conducted to examine the changes
in the mechanical threshold immediately before and 2, 7, 14, and
21 days after SNL in sham (n=6) or DLF-lesioned (n=6) rats. The
threshold for mechanical stimulation of each rat was evaluated al-
ways in the morning between 9:00 and 10:00 h at each day of
experiment.
Data analysis
The mechanical threshold is reported as the mean±SD. Compari-
sons between the control (sham) and test groups were made using a
multivariate analysis of variance (MANOVA) with repeated measures
to compare the groups over time. The factors analyzed included treat-
ments, time and the treatment×time interaction. A one-way analysis
of variance followed by a Bonferroni post hoc test was conducted in
the case of a signiﬁcant treatment×time interaction. The analysis
was performed using GraphPad Prism version 5.00 for Windows
(GraphPad Software, San Diego, CA, USA). The values of F (and the re-
spective degrees of freedom indicated as subscripts) are shown in Re-
sults. The level of signiﬁcance was set at pb0.05.
Results
Our ﬁrst experiment examined changes in the mechanical thresh-
old following an SNL in sham or DLF-lesioned rats. The threshold for
mechanical stimulation of each rat was evaluated prior to surgery
and 2, 7, 14, and 21 days after surgery. The results revealed that the
mechanical threshold of the experimental groups did not signiﬁcantly
differ before the surgical procedure (Fig. 1A). In addition, a sham SNL
in sham (control) or DLF-lesioned rats did not produce a signiﬁcant
change in the behavioral response to tactile stimuli over the entire
observation period. In contrast, SNL rats displayed a signiﬁcant reduc-
tion in the mechanical threshold beginning on the second day after
surgery. This behavioral hypersensitivity to mechanical stimulation
remained unchanged in sham DLF-lesioned rats throughout the ob-
servation period. Behavioral hypersensitivity to mechanical stimula-
tion also occurred in SNL/DLF-lesions rats at post-surgical days 2
and 7; however, the threshold of the SNL/DLF animals displayed a
gradual and signiﬁcant return to pre-surgical values at post-surgical
days 14 and 21. The data in Fig. 1A were signiﬁcantly different in
Fig. 1. Time course of changes in the mechanical threshold as measured in the plantar
skin of the right hind paw of rats submitted to an ipsilateral sham (sSNL) or real (SNL)
spinal nerve ligation and bilateral sham (sDLF) or real (DLF) lesion of the dorsolateral
funiculus. Data in (A) are represented as the mean (± SD) of 6 rats per group. The ex-
tent of the DLF lesion is shown in the insert on images from Paxinos and Watson
(2005). pb0.05 compared to sDLF/sSNL (*) or to the remaining groups (#) of animals.
Representative panoramic microscope images taken from neutral red-stained spinal
cord slices of sham DLF-lesioned and DLF-lesioned rats are shown in (B) and
(C), respectively. Fig. 2. Time course of the changes produced by the intrathecal injection of saline (sal=
5 μl) or gabapentin (gab=200 μg/5 μl) on the mechanical threshold measured in the
plantar skin of the right (IL) or left (CL) hind paw of SNL/sDLF lesion rats, 2 (A) or 7
(B) days after sham (square symbols) or real (circle symbols) ligation of the right L5
and L6 spinal nerves. The animals were tested before surgery (BL1), immediately
before (BL2) and 2 h after (BL3) catheter implantation, and 15 min after intrathecal in-
jection and then at 30 min intervals for up to 105 min. Data are represented as the
mean±SD of 5 animals. (*) Different from sal/IL group (pb0.05).
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25.35; pb0.0001). There was also a signiﬁcant treatment×time inter-
action (F28,160=9.61; pb0.0001). The extent of the DLF lesion
(Fig. 1A, insert) shows that the tissue damage was restricted to the
DLF and the adjacent dorsal horn. Representative panoramic micro-
scope images showing sham DLF-lesioned and DLF-lesioned spinal
cords are shown in Fig. 1B and C, respectively. The remaining experi-
ments were conducted on rats 2 or 7 days after surgery because this
time period displayed signiﬁcant changes in the mechanical thresh-
olds of SNL/DLF-lesioned and SNL/sham DLF-lesioned rats when
compared with the control group.
Our next experiment examined changes induced by the intrathe-
cal injection of gabapentin (200 μg/5 μl) or saline (5 μl) on the me-
chanical threshold of SNL/sham DLF-lesioned rats measured 2
(Fig. 2A) and 7 (Fig. 2B) days after surgery. Gabapentin- and
saline-treated rats did not signiﬁcantly differ in the threshold of
their uninjured (contralateral) hind paw at any point during the
study. Two days after surgery, a signiﬁcant reduction of the mechan-
ical threshold was observed in the injured (ipsilateral) hind paw of
gabapentin- and saline-treated groups at BL2 and BL3 when com-
pared with the threshold measured at BL1 or in the contralateral
hind paw. This behavioral hypersensitivity to mechanical stimulation
remained unchanged after the injection of saline, but it was
completely attenuated by the injection of gabapentin (Fig. 2A). Simi-
lar results were obtained from experiments conducted 7 days after
surgery (Fig. 2B). The curves in Fig. 2A and B were signiﬁcantly differ-
ent in regards to treatment (F3,18=51.8 and 124.8, respectively;
pb0.0001) and time (F6,112=9.0 and 16.8, respectively; pb0.0001).There was also a signiﬁcant treatment×time interaction (F18,112=
88.0 and 9.52, respectively; pb0.0001).
The injection of gabapentin (200 μg/5 μl) performed 2 days after
surgery did not produce a signiﬁcant change in the thresholds of ipsi-
lateral or contralateral hind paws of sham SNL/sham DLF-lesioned
rats (Fig. 3A) or sham SNL/DLF-lesioned (Fig. 3B) throughout the pe-
riod of observation. The data displayed in Fig. 3A and B did not differ
with respect to treatment (F1,8=0.0013 and 0.15, respectively;
p≥0.708). There was no signiﬁcant treatment×time interaction
(F6,48=0.61 and 0.15, respectively; p≥0.718). The data shown in
Fig. 3A, but not Fig. 3B, differ in regards to time (F6,48=2.27;
pb0.021 and F6,48=1.73; p=0.13, respectively). The extent of the
DLF lesion in sham SNL/DLF-lesioned rats was restricted to the DLF
and the adjacent dorsal horn (Fig. 3C). Sham DLF lesion/SNL
(Fig. 3D) or DLF lesion/SNL (Fig. 3E) rats showed no change in the
baseline threshold of the contralateral paw; however, these rats had
a signiﬁcant reduction in the mechanical threshold of the ipsilateral
paw. The behavioral hypersensitivity to mechanical stimulation in-
duced by the SNL was fully reversed by an intrathecal injection of
gabapentin (200 μg/5 μl) in both groups throughout the period of ob-
servation. The results shown in Fig. 3D and E differ with regards to
treatment (F1,8=7.45; p=0.025 and F1,8=16.27; p=0.0038, respec-
tively) and time (F6,48=4.5; p=0.0011 and F6,6=10.61; pb0.0001,
Fig. 3. Time course of the effects of an intrathecal injection of gabapentin (200 μg/5 μl) on the mechanical threshold measured in the plantar skin of the hind paws of rats 2 days
after sham (A–C) or real (D and E) ligation of the right L5 and L6 spinal nerves. The experiments were conducted on rats with a sham (A and D) or real (B and E) DLF lesion. The
animals were tested before surgery (BL1), immediately before (BL2) and 2 h after (BL3) catheter implantation, and 15 min after intrathecal injection and then at 30 min intervals
for up to 105 min. The columns represent the mean±SD of 5 animals per group. (*) different from the contralateral paw; (X) different from the contralateral and ipsilateral paws at
BL1; (#) different from the ipsilateral paw at BL2 and BL3 (pb0.05). The extent of the DLF lesion in sham (C) and real spinal nerve ligated (F) rats is shown in images from Paxinos
and Watson (2005).
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found to have a signiﬁcant treatment×time interaction (F6,48=
3.54; p=0.0055 and F6,48=2.25; p=0.053, respectively). The extent
of the lesion in SNL/DLF-lesioned rats was restricted to the DLF and
the adjacent dorsal horn (Fig. 3F).
Intrathecal gabapentin (200 μg/5 μl) that was administered 7 days
after surgery did not produce signiﬁcant changes in the mechanical
threshold of the ipsilateral or contralateral hind paw of sham SNL/
sham DLF-lesioned rats (Fig. 4A) or sham SNL/DLF-lesioned rats
(Fig. 4B). The results displayed in Fig. 4A and B did not signiﬁcantly
differ in treatment (F1,8=1.42 and 0.65, respectively; p≥0.26), nor
had a signiﬁcant treatment×time interaction (F6,48=0.19 and 0.40, re-
spectively; p≥0.87). The results shown in Fig. 4B, but not in Fig. 4A, dif-
fer regarding time (F6,48=11.72; pb0.0001 and F=1.66; p=0.15,
respectively). The extent of the spinal lesion in sham SNL/DLF-lesioned
rats was restricted to the DLF and the adjacent dorsal horn (Fig. 4C).
SNL/sham DLF-lesioned (Fig. 4D) or SNL/DLF-lesioned (Fig. 4E) rats
showed a signiﬁcant reduction of the mechanical threshold in the ipsi-
lateral paw; however, no signiﬁcant change was observed in the base-
line threshold of the contralateral paw. The SNL-induced behavioral
hypersensitivity to mechanical stimulation was fully reversed in
sham- and DLF-lesioned rats with the administration of gabapentinthroughout the period of observation. The data shown in Fig. 4D and
F differ with regard to treatment (F1,8=31.64 and 34.07, respectively;
pb0.0005) and time (F6,48=14.74 and 15.61, respectively; pb0.0001),
and had a signiﬁcant treatment×time interaction (F6,48=6.1 and 9.05,
respectively; pb0.0001). The extent of the lesion in SNL/DLF-lesioned
rats was restricted to the DLF and the adjacent dorsal horn (Fig. 4F).
Discussion
Our results conﬁrm that an SNL produces behavioral hypersensi-
tivity to mechanical stimulation beginning 2 days after surgery that
continues for at least 3 weeks as previously reported (Kim and
Chung, 1992). In addition, a DLF lesion did not change the onset of
the SNL-induced behavioral hypersensitivity to mechanical stimula-
tion; however, this behavioral hypersensitivity to mechanical stimu-
lation progressively returned to pre-surgical values at post-surgical
days 14 and 21 as shown previously (Burgess et al., 2002). The exper-
iments reported here were conducted 2–7 days after SNL, a period
during which the mechanical thresholds of SNL/sham DLF- and SNL/
DLF-lesioned rats were not signiﬁcantly different. This was done be-
cause the onset of neuropathic pain is likely to be mediated by an in-
creased afferent drive occurring shortly after the injury (Burgess et
Fig. 4. Time course of the effects of intrathecal injection of gabapentin (200 μg/5 μl) on the mechanical threshold measured in the plantar skin of the hind paws of rats 7 days after a
sham (A–C) or real (D and E) ligation of the right L5 and L6 spinal nerves. The experiments were conducted on rats with a sham (A and D) or real (B and E) DLF lesion. The animals
were tested before surgery (BL1), immediately before (BL2) and 2 h after (BL3) catheter implantation, and 15 min after intrathecal injection and then at 30 min intervals for up to
105 min. The columns represent the mean±SD of 5 animals per group. (*) different from the contralateral paw; (X) different from the contralateral and ipsilateral paws at BL1; (#) dif-
ferent from the ipsilateral paw at BL2 and BL3 (pb0.05). The extent of the DLF lesion in sham (C) and real SNL (F) rats is shown in images from Paxinos and Watson (2005).
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of descending axons that travel through the DLF (Millan, 2002), and it
has been implicated in the inhibition and facilitation of spinal noci-
ceptive transmission (Gebhart, 2004; Jones and Gebhart, 1988). The
enhanced activity of afferent primary neurons is not enough to main-
tain the neuropathic state in the absence of a time-related develop-
ment of descending facilitation arising from the RVM (Ren and
Dubner, 2002).
Intraspinal gabapentin at doses above 300 μg causes no signiﬁcant
change in the motor function but produces signiﬁcant sedation
(Hwang and Yaksh (1997). By this reason, gabapentin 200 μg was
chosen for the present study because it does not cause sedation. In
addition, it did not change the mechanical threshold of sham SNL
rats that had either a sham or real DLF lesion. In contrast, intrathecal
gabapentin fully inhibited the SNL-induced behavioral hypersensitiv-
ity to mechanical stimulation in the injured hind paw of rats with
a sham DLF lesion. This result was conﬁrmed for injections of
gabapentin performed at 2 or 7 days after surgery, and it corroborates
earlier evidence that suggests that intrathecal gabapentin is efﬁcient
at mitigating neuropathic pain (Cho et al., 2002; Chu et al., 2011;
Coderre et al., 2005; Hwang and Yaksh, 1997; Wallin et al., 2002).
However, intrathecal gabapentin did not change the mechanical
threshold of the uninjured hind paw nor the mechanical threshold
of sham SNL/sham DLF-lesioned rats. The supraspinal administration
of gabapentin has been shown to be analgesic only after peripheralnerve injury (Tanabe et al., 2005). Wemay then conclude that regard-
less of the site of action, the analgesic effect of gabapentin depends on
the presence of persistent noxious input.
The effect of gabapentin against SNL-induced behavioral hyper-
sensitivity to mechanical stimulation was not modiﬁed in animals
with a previous DLF lesion. This result indicates that the integrity of
the descending ﬁbers projecting to the spinal cord via the DLF is not
necessary for the spinal action of gabapentin against neuropathic
pain. This conclusion diverges from the previous demonstration that
gabapentin acts supraspinally to activate descending noradrenergic
system in mice with peripheral nerve injury (Takasu et al., 2006;
Takeuchi et al., 2007; Tanabe et al., 2005). Our experiment corrobo-
rates previous results that show that the spinally mediated analgesic
effect of gabapentin is not accompanied by changes in spinal mono-
aminergic activities; therefore, the effect is not dependent on the
evoked spinal release of noradrenaline and serotonin. However, the
analgesia induced by intrathecal gabapentin is less intense after
blockade of spinal α2-adrenoceptors (Tanabe et al., 2005). It is likely
that the effect of intrathecal gabapentin against neuropathic pain
requires basal noradrenergic activity (Takeuchi et al., 2007).
Gabapentin binds speciﬁcally to the α2δ-1 subunit of voltage-
dependent calcium channels (Gee et al., 1996). Previously, dorsal
root ganglion and spinal cord calcium channels were found to be
up-regulated in a rat model of neuropathic pain (Li et al., 2004;
Luo et al., 2001, 2002). Thus, an alternative mechanism for the
842 Q.M. Dias et al. / Life Sciences 91 (2012) 837–842anti-hyperalgesic effect of intrathecal gabapentin against SNL-
induced behavioral hypersensitivity to mechanical stimulation
includes a decrease in the spinal release of glutamate (Coderre et
al., 2005), substance P and the calcitonin gene-related peptide
(Fehrenbacher et al., 2003) by the terminals of primary afferent neu-
rons via the blockade of calcium channels.
However, our present results do not exclude that the effect of spinal
gabapentin SNL-induced behavioral hypersensitivity to mechanical
stimulation is mediated by noradrenergic bulbospinal projections that
descend to the spinal cord via the ventrolateral funiculus. In fact, nor-
adrenergic innervation to the spinal cord is mainly provided by the
locus coeruleus/subcoeruleus (Millan, 1999), and the stimulation-
induced antinociception from the locus coeruleus is interrupted by
lesioning of the ventrolateral funiculus (Tsuruoka et al., 2004).
Conclusions
The present study conﬁrms that the spinal cord is a site of action
for the mitigating effect of intrathecally administered gabapentin on
SNL-induced behavioral hypersensitivity to mechanical stimulation
in rats, and it excludes that the effect depends on the activation of
nerve ﬁbers that descend to the spinal cord via the DLF.
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